- Home
- KGS vs KNSA Comparison
KGS vs KNSA Comparison
Compare KGS & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KGS
- KNSA
- Stock Information
- Founded
- KGS 2011
- KNSA 2015
- Country
- KGS United States
- KNSA United Kingdom
- Employees
- KGS N/A
- KNSA N/A
- Industry
- KGS
- KNSA Biotechnology: Pharmaceutical Preparations
- Sector
- KGS
- KNSA Health Care
- Exchange
- KGS Nasdaq
- KNSA Nasdaq
- Market Cap
- KGS 3.0B
- KNSA 2.6B
- IPO Year
- KGS 2023
- KNSA 2018
- Fundamental
- Price
- KGS $34.48
- KNSA $40.79
- Analyst Decision
- KGS Strong Buy
- KNSA Strong Buy
- Analyst Count
- KGS 7
- KNSA 7
- Target Price
- KGS $43.86
- KNSA $49.71
- AVG Volume (30 Days)
- KGS 1.1M
- KNSA 531.8K
- Earning Date
- KGS 11-04-2025
- KNSA 10-28-2025
- Dividend Yield
- KGS 5.74%
- KNSA N/A
- EPS Growth
- KGS 224.29
- KNSA N/A
- EPS
- KGS 0.84
- KNSA 0.47
- Revenue
- KGS $1,284,748,000.00
- KNSA $597,973,000.00
- Revenue This Year
- KGS $14.81
- KNSA $62.63
- Revenue Next Year
- KGS $5.94
- KNSA $29.93
- P/E Ratio
- KGS $40.52
- KNSA $84.61
- Revenue Growth
- KGS 19.43
- KNSA 55.68
- 52 Week Low
- KGS $29.25
- KNSA $17.82
- 52 Week High
- KGS $50.43
- KNSA $42.05
- Technical
- Relative Strength Index (RSI)
- KGS 46.04
- KNSA 63.60
- Support Level
- KGS $33.22
- KNSA $37.61
- Resistance Level
- KGS $35.19
- KNSA $39.66
- Average True Range (ATR)
- KGS 1.20
- KNSA 1.66
- MACD
- KGS -0.22
- KNSA 0.13
- Stochastic Oscillator
- KGS 29.70
- KNSA 90.26
About KGS Kodiak Gas Services Inc.
Kodiak Gas Services Inc is an operator of contract compression infrastructure in the United States. It manages business through two operating segments namely Contract Services and Other Services. Contract Services consists of operating Company-owned and customer-owned compression, and gas treating and cooling infrastructure, pursuant to fixed-revenue contracts to enable the production and gathering of natural gas and oil. Other Services consist of a full range of contract services to support the ancillary needs of customers, including station construction, maintenance and overhaul, freight and crane charges, and other time and material-based offerings.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.